This invention provides estrogen receptor modulators of formula 1, having the structure 1 wherein, A is 2 wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.

 
Web www.patentalert.com

< Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase

< Small molecule inhibitors of rotamase enzyme activity

> Galenic formulations of organic compounds

> Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
~ 00225